Cargando…
Drug-Induced Liver Disturbance During the Treatment of COVID-19
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have di...
Autores principales: | Zhai, Guanghua, Li, Meifen, Wang, Ying, Wu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416279/ https://www.ncbi.nlm.nih.gov/pubmed/34483929 http://dx.doi.org/10.3389/fphar.2021.719308 |
Ejemplares similares
-
Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022) -
Gold Nanoparticles Modified With Polyethyleneimine Disturbed the Activity of Drug-Metabolic Enzymes and Induced Inflammation-Mediated Liver Injury in Mice
por: Chen, Hanqing, et al.
Publicado: (2021) -
Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
por: Li, Nana, et al.
Publicado: (2020) -
Association Between Drug Treatments and the Incidence of Liver Injury in Hospitalized Patients With COVID-19
por: Gao, Suyu, et al.
Publicado: (2022) -
Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
por: Huang, Jingjing, et al.
Publicado: (2022)